Monica Diaz
Medical · South Gate, CANPI 1316277700
Payments from drug & device makers
Across 155 payments — averaging $34.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Boehringer Ingelheim$1K
- AstraZeneca$1K
- Bayer$612
- Novo Nordisk$213
- GSK$210
- plus $678 from 12 others
What the payments were for
- Travel & lodging$391%
- Food & beverage$5,33199%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 49 | $1,391 |
| Boehringer Ingelheim | 35 | $1,231 |
| AstraZeneca | 15 | $1,040 |
| Bayer | 17 | $612 |
| Novo Nordisk | 6 | $213 |
| GSK | 9 | $210 |
| Sumitomo Pharma America, Inc. | 3 | $159 |
| Kowa Pharmaceuticals America, Inc. | 3 | $138 |
| Amgen | 5 | $112 |
| Exact Sciences | 4 | $86 |
| Bioventus LLC | 2 | $42 |
| Pfizer | 1 | $27 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Novartis | 1 | $20 |
| AbbVie | 1 | $19 |
| Merck | 1 | $19 |
| Exeltis, USA Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,375 in reported general payments places this provider in the 85th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 113 | $148,089 |
| TrulicityDulaglutide | 40 | $57,052 |
| OzempicSemaglutide | 42 | $40,768 |
| RybelsusSemaglutide | 25 | $35,019 |
| KerendiaFinerenone | 37 | $33,843 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 23 | $29,471 |
| SynjardyEmpagliflozin/Metformin Hcl | 33 | $27,018 |
| MounjaroTirzepatide | 17 | $23,223 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $21,494 |
| GemtesaVibegron | 16 | $17,826 |
| FarxigaDapagliflozin Propanediol | 19 | $10,307 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,200 |
| Atorvastatin Calcium | 116 | $1,104 |
| Levothyroxine Sodium | 33 | $837 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 53 | $720 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy | $1,231 | $204,578169 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $1,391 | $80,27657 claims |
| Novo NordiskOzempic, Rybelsus | $213 | $75,78767 claims |
| BayerKerendia | $612 | $33,84337 claims |
| GSKTrelegy Ellipta | $210 | $21,49422 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $159 | $17,82616 claims |
| AstraZenecaFarxiga | $1,040 | $10,30719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 medical providers in California.
Other medical in South Gate
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.